Cargando…
Divergence in perceptions of diabetes control among patients with type 2 diabetes mellitus treated with basal insulin and health care professionals: results from the US Perceptions of Control (POC-US) study
Background: Approximately 60% of the patients with type 2 diabetes mellitus (T2DM) on basal insulin have an HbA1c ≥7%. This analysis of the US Perceptions of Control (POC-US) study aimed to understand US patient and health care professional (HCP) views of diabetes “control,” which may play a role in...
Autores principales: | Tomaszewski, Kenneth J, Allen, Amy, Mocarski, Michelle, Schiffman, Alisa, Kruger, Davida, Handelsman, Yehuda, Heile, Michael, Brod, Meryl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520481/ https://www.ncbi.nlm.nih.gov/pubmed/31190758 http://dx.doi.org/10.2147/PPA.S194598 |
Ejemplares similares
-
Burden of Illness in Type 2 Diabetes Mellitus
por: Cannon, Anthony, et al.
Publicado: (2018) -
Health-Related Quality of Life Assessments with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus
por: Billings, Liana K., et al.
Publicado: (2018) -
Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Basal Insulin and Basal-Bolus Therapy in Patients with Type 2 Diabetes Based on Attainment of Clinically Relevant Treatment Targets
por: Cannon, Anthony J., et al.
Publicado: (2020) -
Post-Basal Insulin Intensification and Healthcare Resource Use in Type 2 Diabetes: A Web-Based Physician Survey in the United States and United Kingdom
por: Brod, Meryl, et al.
Publicado: (2019) -
Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues
por: Brod, Meryl, et al.
Publicado: (2007)